{"id":3322,"date":"2018-12-24T14:27:57","date_gmt":"2018-12-24T14:27:57","guid":{"rendered":"https:\/\/csb.eu.com\/en\/?p=3322"},"modified":"2018-12-24T14:27:57","modified_gmt":"2018-12-24T14:27:57","slug":"ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology","status":"publish","type":"post","link":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/","title":{"rendered":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY"},"content":{"rendered":"<p>On 11 May 2017 the Center for the Study of Bioethics organized in cooperation with the Serbian Unit and European Division of the UNESCO Chair in Bioethics, as well as with the Institute for Social Sciences, the lecture &#8220;Ethical Issues Relevant to the Development of Medication in Pediatrics and Challenges of New EU Legislation\u00a0for Clinical Trials in Pediatric Pharmacology&#8221;. The lecturer was Professor Du\u0161anka Krajnovi\u0107 (Faculty of Pharmacy, \u00a0University of Belgrade).\u00a0Milo\u0161 Nikolin moderated the lecture.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-3323 aligncenter\" src=\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\" alt=\"\" width=\"600\" height=\"337\" srcset=\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg 600w, https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017-300x169.jpg 300w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 11 May 2017 the Center for the Study of Bioethics organized in cooperation with the Serbian Unit and European Division of the UNESCO Chair in Bioethics, as well as with the Institute for Social Sciences, the lecture &#8220;Ethical Issues Relevant to the Development of Medication in Pediatrics and Challenges of New EU Legislation\u00a0for Clinical&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[24],"tags":[],"class_list":["post-3322","post","type-post","status-publish","format-standard","hentry","category-events-2017","category-24","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics\" \/>\n<meta property=\"og:description\" content=\"On 11 May 2017 the Center for the Study of Bioethics organized in cooperation with the Serbian Unit and European Division of the UNESCO Chair in Bioethics, as well as with the Institute for Social Sciences, the lecture &#8220;Ethical Issues Relevant to the Development of Medication in Pediatrics and Challenges of New EU Legislation\u00a0for Clinical&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"Center for the Study of Bioethics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/1572291592985845\/?locale=sr_RS\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-24T14:27:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\" \/>\n<meta name=\"author\" content=\"centarzbs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@CBSBelgrade\" \/>\n<meta name=\"twitter:site\" content=\"@CBSBelgrade\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"centarzbs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\"},\"author\":{\"name\":\"centarzbs\",\"@id\":\"https:\/\/csb.eu.com\/en\/#\/schema\/person\/b40085ac27c3a2117846ddfb9ff58beb\"},\"headline\":\"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY\",\"datePublished\":\"2018-12-24T14:27:57+00:00\",\"dateModified\":\"2018-12-24T14:27:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\"},\"wordCount\":98,\"publisher\":{\"@id\":\"https:\/\/csb.eu.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\",\"articleSection\":[\"Events 2017\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\",\"url\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\",\"name\":\"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics\",\"isPartOf\":{\"@id\":\"https:\/\/csb.eu.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\",\"datePublished\":\"2018-12-24T14:27:57+00:00\",\"dateModified\":\"2018-12-24T14:27:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage\",\"url\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\",\"contentUrl\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg\",\"width\":600,\"height\":337},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/csb.eu.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/csb.eu.com\/en\/#website\",\"url\":\"https:\/\/csb.eu.com\/en\/\",\"name\":\"Center for the Study of Bioethics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/csb.eu.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/csb.eu.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/csb.eu.com\/en\/#organization\",\"name\":\"Center for the Study of Bioethics\",\"url\":\"https:\/\/csb.eu.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csb.eu.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/logo3-263x300-1.png\",\"contentUrl\":\"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/logo3-263x300-1.png\",\"width\":263,\"height\":300,\"caption\":\"Center for the Study of Bioethics\"},\"image\":{\"@id\":\"https:\/\/csb.eu.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/groups\/1572291592985845\/?locale=sr_RS\",\"https:\/\/x.com\/CBSBelgrade\",\"https:\/\/x.com\/vojiner\",\"https:\/\/x.com\/vojin2015\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/csb.eu.com\/en\/#\/schema\/person\/b40085ac27c3a2117846ddfb9ff58beb\",\"name\":\"centarzbs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csb.eu.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/80f2f22f35dd22e3540f9a5b742ea2e5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/80f2f22f35dd22e3540f9a5b742ea2e5?s=96&d=mm&r=g\",\"caption\":\"centarzbs\"},\"url\":\"https:\/\/csb.eu.com\/en\/author\/centarzbs\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/","og_locale":"en_US","og_type":"article","og_title":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics","og_description":"On 11 May 2017 the Center for the Study of Bioethics organized in cooperation with the Serbian Unit and European Division of the UNESCO Chair in Bioethics, as well as with the Institute for Social Sciences, the lecture &#8220;Ethical Issues Relevant to the Development of Medication in Pediatrics and Challenges of New EU Legislation\u00a0for Clinical&hellip;","og_url":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/","og_site_name":"Center for the Study of Bioethics","article_publisher":"https:\/\/www.facebook.com\/groups\/1572291592985845\/?locale=sr_RS","article_published_time":"2018-12-24T14:27:57+00:00","og_image":[{"url":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg"}],"author":"centarzbs","twitter_card":"summary_large_image","twitter_creator":"@CBSBelgrade","twitter_site":"@CBSBelgrade","twitter_misc":{"Written by":"centarzbs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#article","isPartOf":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/"},"author":{"name":"centarzbs","@id":"https:\/\/csb.eu.com\/en\/#\/schema\/person\/b40085ac27c3a2117846ddfb9ff58beb"},"headline":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY","datePublished":"2018-12-24T14:27:57+00:00","dateModified":"2018-12-24T14:27:57+00:00","mainEntityOfPage":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/"},"wordCount":98,"publisher":{"@id":"https:\/\/csb.eu.com\/en\/#organization"},"image":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg","articleSection":["Events 2017"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/","url":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/","name":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY - Center for the Study of Bioethics","isPartOf":{"@id":"https:\/\/csb.eu.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage"},"image":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage"},"thumbnailUrl":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg","datePublished":"2018-12-24T14:27:57+00:00","dateModified":"2018-12-24T14:27:57+00:00","breadcrumb":{"@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#primaryimage","url":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg","contentUrl":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/Dogadjaji_21_2017.jpg","width":600,"height":337},{"@type":"BreadcrumbList","@id":"https:\/\/csb.eu.com\/en\/events-2017\/ethical-issues-relevant-to-the-development-of-medication-in-pediatrics-and-challenges-of-new-eu-legislation-for-clinical-trials-in-pediatric-pharmacology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/csb.eu.com\/en\/"},{"@type":"ListItem","position":2,"name":"ETHICAL ISSUES RELEVANT TO THE DEVELOPMENT OF MEDICATION IN PEDIATRICS AND CHALLENGES OF NEW EU LEGISLATION FOR CLINICAL TRIALS IN PEDIATRIC PHARMACOLOGY"}]},{"@type":"WebSite","@id":"https:\/\/csb.eu.com\/en\/#website","url":"https:\/\/csb.eu.com\/en\/","name":"Center for the Study of Bioethics","description":"","publisher":{"@id":"https:\/\/csb.eu.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/csb.eu.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/csb.eu.com\/en\/#organization","name":"Center for the Study of Bioethics","url":"https:\/\/csb.eu.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csb.eu.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/logo3-263x300-1.png","contentUrl":"https:\/\/csb.eu.com\/en\/wp-content\/uploads\/logo3-263x300-1.png","width":263,"height":300,"caption":"Center for the Study of Bioethics"},"image":{"@id":"https:\/\/csb.eu.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/1572291592985845\/?locale=sr_RS","https:\/\/x.com\/CBSBelgrade","https:\/\/x.com\/vojiner","https:\/\/x.com\/vojin2015"]},{"@type":"Person","@id":"https:\/\/csb.eu.com\/en\/#\/schema\/person\/b40085ac27c3a2117846ddfb9ff58beb","name":"centarzbs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csb.eu.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/80f2f22f35dd22e3540f9a5b742ea2e5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80f2f22f35dd22e3540f9a5b742ea2e5?s=96&d=mm&r=g","caption":"centarzbs"},"url":"https:\/\/csb.eu.com\/en\/author\/centarzbs\/"}]}},"_links":{"self":[{"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/posts\/3322"}],"collection":[{"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/comments?post=3322"}],"version-history":[{"count":2,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/posts\/3322\/revisions"}],"predecessor-version":[{"id":3341,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/posts\/3322\/revisions\/3341"}],"wp:attachment":[{"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/media?parent=3322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/categories?post=3322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csb.eu.com\/en\/wp-json\/wp\/v2\/tags?post=3322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}